Olopatadine 0.6% nasal spray protects from vasomotor challenge in patients with severe vasomotor rhinitis

American Journal of Rhinology and Allergy

Volumn 25, Issue 4, 2011, Pages

  Smith, Peter K ^a   Collins, Joel ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MANNITOL; NOSE SPRAY; OLOPATADINE; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FLOW RATE; HUMAN; MALE; OUTCOME ASSESSMENT; PEAK NASAL INSPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VASOMOTOR RHINITIS;

ADOLESCENT; ADULT; AGED; CAPSAICIN; DIBENZOXEPINS; DISEASE PROGRESSION; FEMALE; HUMANS; INSPIRATORY CAPACITY; MALE; MIDDLE AGED; NASAL OBSTRUCTION; NASAL PROVOCATION TESTS; NASAL SPRAYS; RHINITIS, VASOMOTOR;

EID: 79960445703     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2011.25.3620     Document Type: Article

References (59)

1. Bousquet J, van Cauwenberge P, Khaltaev N, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA) in collaboration with the World Health Organization (WHO). J Allergy Clin Immunol 108:S147-S336, 2001.
2. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol. 122:S1-S84, 2008. (Pubitemid 352033573)
3. Bernstein JA. Allergic and mixed rhinitis: Epidemiology and natural history. Allergy Asthma Proc 31:365-369, 2010.
4. Togias A. Age relationships and clinical features of nonallergic rhinitis. J Allergy Clin Immunol. 85:182, 1990.
5. Brandt D, and Bernstein JA. Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis. Ann Allergy Asthma Immunol 96:526-532, 2006.
6. Braat J, Mulder P, Fokkens W, et al. Intranasal cold dry air is superior to histamine challenge in determining the presence and degree of nasal hyperreactivity in nonallergic noninfectious perennial rhinitis. Am J Respir Crit Care Med 157:1748-1755, 1998.
7. Togias A, Lykens K, Kagey-Sobotka A, et al. Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose. Am Rev Respir Dis 141:1428-1433, 1990. (Pubitemid 20201337)
8. Bousquet J, Bachert C, Canonica GW, et al. Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol 124:428-433, 2009.
9. Ciprandi G. Treatment of nonallergic perennial rhinitis. Allergy 59(suppl 76):16-23, 2004. (Pubitemid 38167972)
10. Sanico AM, Philip G, Proud D, et al. Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: Effects of capsaicin nasal challenge. Clin Exp Allergy 28:92-100, 1998. (Pubitemid 28053932)
11. Wolf G, Anderhuber W, Hauser- Kronberger C, and Saria A. Treatment of nonspecific hyper-reflectory rhinopathy (vasomotor rhinitis) with capsaicin. Laryngorhinootologie 74:289-293, 1995.
12. Riechelmann H, Davris S, and Bader D. Treatment of perennial non-allergic rhinopathy with capsaicin. HNO 41:475-479, 1993. (Pubitemid 23324028)
13. Marabini S, Ciabatti PG, Polli G, et al. Beneficial effects of intranasal applications of capsaicin in patients with vasomotor rhinitis. Eur Arch Otorhinolaryngol 248:191-194, 1991.
14. van Rijswijk JB, Boeke EL, Keizer JM, et al. Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis: A doubleblind randomised application regimen study. Allergy 58:754-761, 2003. (Pubitemid 36920465)
15. Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 389:816-824, 1997. (Pubitemid 27462969)
16. Levine JD, and Alessandri-Haber N. TRP channels: Targets for the relief of pain. Biochim Biophys Acta 1772:989-1003, 2007. (Pubitemid 47176368)
17. Seki N, Shirasaki H, Kikuchi M, et al. Expression and localization of TRPV1 in human nasal mucosa. Rhinology 44:128-134, 2006. (Pubitemid 43862939)
18. Taylor-Clark T, Kollarik M, MacGlashan D, and Undem B. Nasal sensory nerve populations responding to histamine and capsaicin. J Allergy Clin Immunol 116:1282-1288, 2005. (Pubitemid 41740938)
19. Trevisani M, Smart D, Gunthorpe MJ, et al. Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat Neurosci 5:546-551, 2002. (Pubitemid 34568996)
20. Macpherson LJ, Geierstanger BH, Viswanath V, et al. The pungency of garlic: Activation of TRPA1 and TRPV1 in response to allicin. Curr Biol 15:929-934, 2005. (Pubitemid 40772062)
21. Hwang SW, Cho H, Kwak J, et al. Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances. Proc Natl Acad Sci USA 97:6155-6160, 2000. (Pubitemid 30367539)
22. Premkumar LS, Qi ZH, Van Buren J, and Raisinghani M. Enhancement of potency and efficacy of NADA by PKC-mediated phosphorylation of vanilloid receptor. J Neurophysiol 91:1442-1449, 2004. (Pubitemid 38250421)
23. Julius D, and Basbaum AI. Molecular mechanisms of nociception. Nature 413:203-210, 2001. (Pubitemid 32867885)
24. Zygmunt PM, Petersson J, Andersson DA, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:452-457, 1999. (Pubitemid 29361798)
25. Vlachova V, Teisinger J, Susankova K, et al. Functional role of C-terminal cytoplasmic tail of rat vanilloid receptor 1. J Neurosci 23:1340-1350, 2003. (Pubitemid 36258912)
26. Varga A, Bolcskei K, Szoke E, et al. Relative roles of protein kinase A and protein kinase C in modulation of transient receptor potential vanilloid type 1 receptor responsiveness in rat sensory neurons in vitro and peripheral nociceptors in vivo. Neuroscience 140:645-657, 2006.
27. Vellani V, Mapplebeck S, Moriondo A, et al. Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat, and anandamide. J Physiol 534:813-825, 2001. (Pubitemid 32700878)
28. Rathee PK, Distler C, Obreja O, et al. PKA/AKAP/VR-1 module: A common link of Gs-mediated signaling to thermal hyperalgesia. J Neurosci 22:4740-4745, 2002. (Pubitemid 37465689)
29. Jin X, Morsy N, Winston J, et al. Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase. Am J Physiol Cell Physiol 287:C558-C563, 2004. (Pubitemid 38955247)
30. Prescott ED, and Julius D. A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity. Science 300:1284-1288, 2003. (Pubitemid 36618238)
31. Steffee CH, Lantz PE, Flannagan LM, et al. Oleoresin capsicum (pepper) spray and "in-custody deaths." Am J Forensic Med Pathol 16:185-192, 1995.
32. Ohmori K, Hayashi K, Kaise T, et al. Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug. Jpn J Pharmacol 88:379-397, 2002. (Pubitemid 34516564)
33. Ratner PH, Hampel FC, Amar NJ, et al. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar. Ann Allergy Asthma Immunol 95:474-479, 2005. (Pubitemid 41688510)
34. Meltzer EO, Hampel FC, Ratner PH, et al. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 95:600-606, 2005. (Pubitemid 43010489)
35. Kaise T, Yukino A, Kenji O, et al. Inhibitory effect of olopatadine. Hydrochloride on the sneezing response induced by intranasal capsaicin challenge in guinea pigs. Jpn J Pharmacol 86:258-261, 2001.
36. Ahern GP, Brooks IM, Miyares RL, and Wang XB. Extracellular cations sensitize and gate capsaicin receptor TRPV1 modulating pain signaling. J Neurosci 25:5109-5116, 2005. (Pubitemid 40726964)
37. Koskela H, Hyvärinen L, Brannan JD, et al. Sensitivity and validity of three bronchial provocation tests to demonstrate the effect of inhaled corticosteroids in asthma. Chest 124:1341-1349, 2003. (Pubitemid 37290044)
38. Porsbjerg C, Brannan JD, Anderson SD, and Backer V. Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients. Clin Exp Allergy 38:43-50, 2008. (Pubitemid 350233397)
39. Enomoto T, Lu H-Q, Yin M, et al. Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit. J Investig Allergol Clin Immunol 19:299-305, 2009.
40. Hampel FC Jr, Ratner PH, Amar NJ, et al. Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo. Allergy Asthma Proc 27:202-207, 2006. (Pubitemid 44153865)
41. Patel D, Garadi R, Brubaker M, et al. Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: Olopatadine hydrochloride versus mometasone furoate monohydrate. Allergy Asthma Proc 28:592-599, 2007.
42. Patel P, Roland PS, Marple BF, et al. An assessment of the onset and duration of action of olopatadine nasal spray. Otolaryngol Head Neck Surg 137:918-924, 2007. (Pubitemid 350117069)
43. Good DM, Clapham JC, and Hamilton TC. Effects of BRL38227 on neurally mediated responses in the guinea-pig isolated bronchus. Br J Pharmacol 105:933-940, 1992.
44. Ikemura T, Manabe H, Sasaki Y, et al. KW-4679, an antiallergic drug, inhibits the production of inflammatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophils. Int Arch Allergy Immunol 110:57-63, 1996. (Pubitemid 26116034)
45. Moriyama T, Higashi T, Togashi K, et al. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol Pain 1:3, 2005.
46. Moriyama T, Iida T, Kobayashi K, et al. Possible involvement of P2Y2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity. J Neurosci 23:6058-6062, 2003. (Pubitemid 36868990)
47. Chuang HH, Prescott ED, Kong H, et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 411:957-962, 2001.
48. Kim BM, Lee SH, Shim WS, and Oh U. Histamine-induced Ca(2+) influx via the PLA(2)/lipoxygenase/TRPV1 pathway in rat sensory neurons. Neurosci Lett 361:159-162, 2004.
49. Shim WS, Tak MH, Lee MH, et al. TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase. J Neurosci 27:2331-2337, 2007.
50. Dai Y, Moriyama T, Higash T, et al. Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J Neurosci 24:4293-4299, 2004. (Pubitemid 38612819)
51. Amadesi S, Nie J, Vergnolle N, et al. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci 24:4300-4312, 2004. (Pubitemid 38608141)
52. Hu HJ, Bhave G, and Gereau RW. Prostaglandin and protein kinase A-dependent modulation of vanilloid receptor function by metabotropic glutamate receptor 5: Potential mechanism for thermal hyperalgesia. J Neurosci 22:7444-7452, 2002. (Pubitemid 35386344)
53. Ji RR, Samad TA, Jin SX, et al. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36:57-68, 2002.
54. Howard S, Chan Yeung M, Martin L, et al. Polyphosphoinositide hydrolysis and protein kinase C activation in guinea pig tracheal smooth muscle cells in culture by leukotriene D4 involve a pertussis toxin sensitive G-protein. Eur J Pharmacol 227:123-129, 1992.
55. Ragozzino D. CXC chemokine receptors in the central nervous system: Role in cerebellar neuromodulation and development. J Neurovirol 8:559-572, 2002. (Pubitemid 36104720)
56. Diogenes A, Patwardhan AM, Jeske NA, et al. Prolactin modulates TRPV1 in female rat trigeminal sensory neurons. J Neurosci 26:8126-8136, 2006. (Pubitemid 44315137)
57. Sharif NA, Xu SX, and Yanni JM. Olopatadine (AL-4943A): Ligand binding and functional studies on a novel, long acting selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis. J Ocular Pharm Ther 12:401-407, 1996. (Pubitemid 26405744)
58. Shin J, Cho H, Hwang SW, et al. Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci USA 99:10150-10155, 2002. (Pubitemid 34831187)
59. Lee SB, and Rhee SG. Significance of PIP2 hydrolysis and regulation of phospholipase C isozymes. Curr Opin Cell Biol 7:183-189, 1995.